EugeniaGirdaMD

Obstetrics & Gynecology • New Brunswick, NJ

Gynecologic Oncology

Join to view full profile

Dr. Girda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Girda's full profile

Already have an account?

Office
195 Little Albany Street
New Brunswick, NJ 08903
Phone+1 732-235-8521

Fax+1 732-235-7258
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Obstetrics and Gynecology, 2010 - 2014
Stony Brook University Health Sciences Center School of MedicineClass of 2010
University of California Davis HealthFellowship, Gynecologic Oncology

Certifications & Licensure

CA State Medical License 2014 - Present
NJ State Medical License 2017 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Start of enrollment: 2014 Oct 27
Completed
Phase 1
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Start of enrollment: 2015 Dec 18
Recruiting
Phase 2
A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2016 Oct 31
Completed
Phase 1, Phase 2
A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors Start of enrollment: 2016 Nov 15
Active, not recruiting
Phase 1
Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer Start of enrollment: 2017 Mar 10
Active, not recruiting
Phase 1
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies Start of enrollment: 2017 Oct 09
Completed
Phase 1, Phase 2
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2018 Oct 12
Active, not recruiting
Phase 2
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol Start of enrollment: 2020 Jan 15
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.
Garbuzenko, O., Sapiezynski, J., Minko, T., Girda, E., Rodriguez-Rodriguez, L.> ;Small. 2024 Feb 11
A Report of a Rare Case of Rapidly Progressing Immature Teratoma With Associated Splenic Metastasis and Gliomatosis Peritonei.
Anusha Adkoli, Colton Smith, Timothy Kennedy, James Aikins, Eugenia Girda> ;Cureus. 2024 Feb 1
Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.
Eugenia Girda, Leslie M Randall, Fumiko Chino, Bradley J Monk, John H Farley, Roisin E O'Cearbhaill> ;Gynecologic Oncology. 2023 Dec 1
Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.
Ritesh Kumar, Melissa Lopez, Irina Vergalasova, Xinxin Zhang, Brett Eckroate, Jessie Hollingsworth, Eugenia Girda, Lara Hathout, Sherwani, Z.> ;Gynecologic Oncology. 2023 Dec 1
Challenges in treatment of gestational trophoblastic neoplasia in patients with MTHFR mutation: A case report.
Jharna M Patel, Danielle Glassman, Sapna Sayal, Eugenia Girda> ;Gynecologic Oncology Reports. 2023 Aug 1
1 citations
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
Eduardo Gonzalez-Ochoa, Michael Milosevic, Bradley Corr, James L Abbruzzese, Eugenia Girda, Rachel W Miller, Jennifer Croke, Helen Mackay, Yeh Chen Lee, Valerie Boweri...> ;International Journal of Gynecological Cancer. 2023 Aug 7
1 citations
Publication rates of podium presentations at the Society of Gynecologic Oncology (SGO) annual meetings.
Katherine Jane Chua, Samira Moughrabi, Danielle Glassman, Samer Habib, Eric A Singer, Eugenia Girda> ;International Journal of Gynecological Cancer. 2023 Aug 7
84 citations
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope, Fernanda B Musa, Robert Mannel, Mark S Shahin, Guilherme H Cantuaria, Eugenia Girda, C...> ;The New England Journal of Medicine. 2023 Jun 8
4 citations
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy.
Tenley R Klc, Sharon Wu, Annelise M Wilhite, Nathaniel L Jones, Matthew A Powell, Alex Olawaiye, Eugenia Girda, Jubilee Brown, Allison Puechl, Rouba Ali-Fehmi, Ira S W...> ;Gynecologic Oncology. 2022 Nov 1
19 citations
Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study.
Ronnie Shapira-Frommer, Linda Mileshkin, Ludmila Manzyuk, Nicolas Penel, Matthew Burge, Sarina A Piha-Paul, Eugenia Girda, Jose A Lopez Martin, Marloes G J van Dongen,...> ;Gynecologic Oncology. 2022 Aug 1
6 citations
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tu...
Ann W Silk, Biren Saraiya, Roman Groisberg, Nancy Chan, Kristen Spencer, Eugenia Girda, Weichung Shih, Marisa Palmeri, Tracie Saunders, Robert M Berman, Vlad Coric, Su...> ;European Journal of Medical Research. 2022 Jul 2
3 citations
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Eugenia Girda, June Hou, David Nelson, Malcolm Finlayson, Alexandre Buckley de Meritens, Marina Chekmareiva, Aliza Leiser, Mihae Song, Ruth Stephenson, Nancy Chan, Ana...> ;International Journal of Gynecological Cancer. 2022 Jun 24
7 citations
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).
Ticiana A Leal, Marina N Sharifi, Nancy Chan, Robert Wesolowski, Anita A Turk, Justine Y Bruce, Ruth M O'Regan, Jens Eickhoff, Lisa M Barroilhet, Jyoti Malhotra, Janic...> ;Cancer Medicine. 2022 Nov 1
1 citations
Benign metastasizing leiomyoma in retroperitoneal lymph nodes with concurrent early stage cervical cancer.
Danielle Glassman, Jharna M Patel, Lara Hathout, Sumi Thomas, Eugenia Girda> ;Gynecologic Oncology Reports. 2022 Apr 1
23 citations
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.
Stephanie Lheureux, Daniela E Matei, Panagiotis A Konstantinopoulos, Ben X Wang, Ramy Gadalla, Matthew S Block, Andrea Jewell, Stephanie L Gaillard, Michael McHale, Ca...> ;Journal for Immunotherapy of Cancer. 2022 Mar 1
89 citations
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
M Palmeri, J Mehnert, A W Silk, S K Jabbour, S Ganesan, P Popli, G Riedlinger, R Stephenson, A B de Meritens, A Leiser, T Mayer, N Chan, K Spencer, E Girda, J Malhotra...> ;ESMO Open. 2022 Feb 1
6 citations
Fetal and Neonatal Outcomes Following Maternal Aortic Balloon Occlusion for Hemorrhage in Pregnancy: A Review of the Literature.
Christina M. Theodorou, Tanya N. Rinderknecht, Eugenia Girda, Joseph M. Galante, Rachel M. Russo> ;The Journal of Trauma and Acute Care Surgery. 2021 Sep 24
1 citations
Vaginal mucositis related to immunotherapy in endometrial cancer
Jharna M. Patel, Michael Enich, Ruth Stephenson, Roman Groinsberg, Eugenia Girda> ;Gynecologic Oncology Reports. 2021 Mar 31
Decompression of hematocolpos caused by acquired obstruction in patient with prior radiation therapy for vaginal cancer.
Adam D Elwood, Eugenia Girda> ;Gynecology & Obstetrics Case Reports. 2021 Jan 1
2 citations
Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation.
Kristen Spencer, Eric A Singer, Eugenia Girda> ;Journal of Cancer Biology. 2021 Jan 1
Recurrent Gallbladder Cancer Presenting as Ovarian Neoplasm: A Case Report.
Jessie Hollingsworth, Jharna M Patel, Eugenia Girda> ;Cancer Studies and Therapeutics. 2020 Oct 1
17 citations
Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic review.
Nikhil Yegya-Raman, Connie D Cao, Lara Hathout, Eugenia Girda, Scott D. Richard, Norman G. Rosenblum, Neil K. Taunk, Salma K. Jabbour> ;Gynecologic Oncology. 2020 Sep 9
7 citations
Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer
Adrian Kohut, Mary Cathryn Earnhardt, Nicholas G. Cuccolo, Mihae Song, Eugenia Girda, Alexandre Buckley de Meritens, Ruth Stephenson, Adrian Balica, Aliza L. Leiser, K...> ;Gynecologic Oncology. 2020 Jan 1
9 citations
Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a...
Marina Frimer, Eirwen M. Miller, Viswanathan Shankar, Eugenia Girda, Keyur J. Mehta, Harriet O. Smith, Dennis Yi-Shin Kuo, Gary L. Goldberg, Mark H. Einstein> ;International Journal of Gynecological Cancer. 2018 Nov 1
41 citations
The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible.
Eugenia Girda, Eric C. Huang, Gary S. Leiserowitz, Lloyd H. Smith> ;International Journal of Gynecological Cancer. 2017 Oct 1
Join now to see all

Lectures

An open-label phase 1 trial of the safety and efficacy of daily subcutaneous SPL-108 injections when used in combination with paclitaxel in patients with platinum-resi...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Splash Pharmaceuticals Announces Clinical Trial Presentation at the 2018 American Society of Clinical Oncology Annual MeetingMay 29th, 2018
Experts Address the Latest on Cervical Cancer TreatmentJanuary 26th, 2024